nfr-logonfr-logo
PROJECT BANK
Switch to English
Statistics
Projects

0 projects

Date from new to old

EIC-The European Innovation Council (EIC)

NEXT GENERATION IMAGING FOR REAL-TIME DOSE VERIFICATION ENABLING ADAPTIVE PROTON THERAPY

The NOVO project will address a fundamental issue in proton radiotherapy (PT) of cancer, namely the lack of real-time dose verification (RDV) that significantly limits the potential of PT due to uncertainties in the precise delivery of the prescribed dose. In the NOVO project, we will develop the...

Awarded: NOK 17.8 mill.

Project Period: 2024-2028

Location: Vestland

CL1-Health

Targeting Epstein-Barr Virus Infection for Treatment and Prevention of Multiple Sclerosis

Targeting Epstein-Barr Virus Infection for Treatment and Prevention of Multiple Sclerosis

Awarded: NOK 29.6 mill.

Project Period: 2023-2028

Location: Buskerud og 5 andre

CL1-Health

TOWARDS LARGE-SCALE ADAPTION AND TAILORED IMPLEMENTATION OF EVIDENCE-BASED PRIMARY CANCER PREVENTION PROGRAMMES IN EUROPE AND BEYOND

The high and growing global burden of cancer urges the need for effective implementation of primary cancer prevention (PCP) programmes targeting modifiable risk factors. However, evidence-based programmes with proven effectiveness under controlled environments often fail when implemented in the r...

Awarded: NOK 1.8 mill.

Project Period: 2023-2027

Location: Vestland

MSCA-Marie Sklodowska-Curie Actions (MSCA)

Determining Genetic Bases of Differential Response to Antipsychotics Using Patient-Derived Neurons

Schizophrenia (SCZ) affects 20 million people worldwide and antipsychotics remain the only effective pharmacological intervention. However, one-third of people with SCZ do not respond to first-line antipsychotic drugs. In the absence of clinical biomarkers to stratify SCZ subtypes, all individual...

Awarded: NOK 3.1 mill.

Project Period: 2023-2025

Location: Vestland

CL1-Health

CANCER PREVENTION VS CANCER TREATMENT: THE RARE TUMOUR RISK SYNDROMES BATTLE

Rare tumour risk syndromes (RTRS) are rare diseases, affecting 5 per 10.000 people or less and caused by heritable genetic variants. In RTRS, the lifetime risk to develop various cancers can be as high as 100%, and patients have a 50% chance of transmitting the disease to their offspring. When un...

Awarded: NOK 3.5 mill.

Project Period: 2023-2025

Location: Vestland

CL1-Health

Fostering a European Research Area for Health Research

Excellent EU programs push health R&I but are not sufficient. Synergy with strategic initiatives in MS and a new model for impactful collaborations are needed to address the challenges for health. ERA4Health brings the opportunity to increase EU transnational collaborative research funding by cre...

Awarded: NOK 15.8 mill.

Project Period: 2022-2029

Location: Vestland og 2 andre

H20-MSCA-Marie Sklodowska-Curie actions

Multiomics based analysis of brain-gut axis: A search for gastrointestinal disease phenotypes

Multiomics based analysis of brain-gut axis: A search for gastrointestinal disease phenotypes

Awarded: NOK 2.1 mill.

Project Period: 2020-2022

Location: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Indo-European Consortium for Next Generation Influenza Vaccine Innovation

Indo-European Consortium for Next Generation Influenza Vaccine Innovation

Awarded: NOK 8.6 mill.

Project Period: 2020-2025

Location: Oslo og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

Living well, dying well. A research programme to support living until the end

Living well, dying well. A research programme to support living until the end

Awarded: NOK 3.3 mill.

Project Period: 2019-2022

Location: Vestland

H20-ERC-European Research Council

Oral bacteria as determinants for respiratory health

Oral bacteria as determinants for respiratory health

Awarded: NOK 14.4 mill.

Project Period: 2019-2023

Location: Vestland

H20-HEALTH-Health, demographic change and wellbeing

conect4children (COllaborative Network for European Clinical Trials For Children)

conect4children (COllaborative Network for European Clinical Trials For Children)

Awarded: NOK 6.5 mill.

Project Period: 2018-2024

Location: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Personalised maxillofacial bone regeneration

Personalised maxillofacial bone regeneration

Awarded: NOK 9.1 mill.

Project Period: 2018-2021

Location: Vestland og 2 andre

H20-INFRA-Research infrastructures

Paediatric Clinical Research Infrastructure Network

Paediatric Clinical Research Infrastructure Network

Awarded: NOK 0.45 mill.

Project Period: 2017-2021

Location: Vestland og 2 andre

H20-MSCA-Marie Sklodowska-Curie actions

Image-Guided Surgery (IGS) and Personalised Postoperative Immunotherapy To Improving Cancer Outcome

Image-Guided Surgery (IGS) and Personalised Postoperative Immunotherapy To Improving Cancer Outcome

Awarded: NOK 5.1 mill.

Project Period: 2016-2019

Location: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Clinical development of a dendritic-cell vaccine therapy for acute myeloid leukaemia

Eradicating minimal residual disease (MRD) in patients with acute myeloid leukaemia (AML) is an area of high unmet medical need. AML is a deadly rare disease that affects both children and adults. Approximately 45% of younger AML patients who are treated will be cured, and in older patients (>60 ...

Awarded: NOK 2.4 mill.

Project Period: 2016-2020

Location: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Female cancer prediction using cervical omics to individualise screening and prevention

While prevention of most female specific cancers (ovarian, breast, endometrial) has not progressed substantially in recent years, significant progress has been made with cervical cancer due to accessibility of the cell of origin (cervical smear) and availability of a test for the causal agent (hu...

Awarded: NOK 2.3 mill.

Project Period: 2015-2020

Location: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Dynamic hormone diagnostics

Dynamic hormone diagnostics

Awarded: NOK 16.7 mill.

Project Period: 2015-2020

Location: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Aging Lungs in European Cohorts

This programme of work will advance the understanding of the combined effects of factors that cause poor lung function, respiratory disability and the development of COPD . This will be achieved by examination of determinants of lung growth and lung function decline within existing cohorts that c...

Awarded: NOK 4.6 mill.

Project Period: 2015-2019

Location: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Regenerative treatment of complete Traumatic Spinal Cord injury with a surgical implantation of a biodegradable device with FGF1 and nerve grafts

Today there is no regenerative therapy available for treatment of complete spinal cord injuries (SCI). BioArctic Neuroscience develops a novel treatment of complete SCI. The method is based on the regeneration of functional nerves in the injured spinal cord. Nerve grafts are transplanted into the...

Awarded: NOK 8.1 mill.

Project Period: 2015-2019

Location: Vestland

SECURITY-1.10 Security

Online and Mobile Communications for Emergencies

Online and Mobile Communications for Emergencies

Awarded: NOK 1.5 mill.

Project Period: 2014-2017

Location: Hordaland

SECURITY-1.10 Security

Online and Mobile Communications for Crisis Response and Search and Rescue

-

Awarded: NOK 0.87 mill.

Project Period: 2013-2015

Location: Hordaland

1